GlassScriptPhysician profile
Deborah Tedesco
NPI 1912956095
$4,598.52
in general payments reported to CMS, 2019-2025
30 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $888 · 2022: $677 · 2023: $1,143 · 2024: $405 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,034.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $511.29 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Gilead Sciences, INC. | $340.10 | 2021-2025 | Livdelzi, Epclusa |
| Novo Nordisk INC | $264.29 | 2021-2025 | Wegovy |
| Neurocrine Biosciences, INC. | $233.08 | 2023 | Ingrezza |
| Abiomed | $228.52 | 2025 | |
| Genentech USA, INC. | $215.53 | 2021-2023 | Evrysdi |
| Sientra, INC. | $205.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $200.38 | 2021-2023 | Farxiga |
| Biogen, INC. | $194.44 | 2022-2023 | |
| Genzyme Corporation | $190.66 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.43 | 2022-2023 | |
| Axogen | $150.00 | 2025 | |
| Novocure INC. | $133.00 | 2025 | Optune Lua (Novottf-200t) |
| Ge Healthcare | $130.18 | 2024 | |
| Shield Therapeutics INC | $125.00 | 2023 | Accrufer |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $124.99 | 2021 | |
| Incyte Corporation | $124.97 | 2021 | |
| Axsome Therapeutics, INC. | $117.12 | 2025 | Auvelity |
| Paratek Pharmaceuticals, INC. | $116.43 | 2023 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.03 | 2021 | |
| Novartis Pharmaceuticals Corporation | $106.37 | 2023 | |
| Puma Biotechnology, INC. | $101.20 | 2021 | |
| Silk Road Medical, INC. | $95.27 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Currax Pharmaceuticals LLC | $92.67 | 2025 | Contrave |
| Grt US Holding, INC. | $88.55 | 2022 | |
| Abbvie INC. | $88.53 | 2022 | |
| Becton, Dickinson and Company | $71.12 | 2025 | Hemosphere |
| Smith+Nephew, INC. | $29.43 | 2021 | |
| Advanced Oxygen Therapy INC. | $25.88 | 2024 | Topical Oxygen Chamber For Extremities |
| Lifenet Health | $23.72 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Tedesco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.